Figure 1.
CONSORT flow diagram. The primary end point, relapse-free survival, was evaluated in 199 eligible patients. Prognostic analysis of MRD was performed on 112 patients whose samples were collected.

CONSORT flow diagram. The primary end point, relapse-free survival, was evaluated in 199 eligible patients. Prognostic analysis of MRD was performed on 112 patients whose samples were collected.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal